Psoriasis and daily low-emission phototherapy: effects on disease and vitamin D level

Background/Purpose Hospital‐based phototherapy is a widely accepted treatment modality in psoriasis patients. It, however, requires several hospital visits weekly, interfering with (school)work. Home ultraviolet (UV) treatment has been proven effective before but is only available in certain countri...

Full description

Saved in:
Bibliographic Details
Published inPhotodermatology, photoimmunology & photomedicine Vol. 31; no. 2; pp. 83 - 89
Main Authors Franken, Sylvie Mireille, Witte, Birgit, Pavel, Stan, Rustemeyer, Thomas
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.03.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background/Purpose Hospital‐based phototherapy is a widely accepted treatment modality in psoriasis patients. It, however, requires several hospital visits weekly, interfering with (school)work. Home ultraviolet (UV) treatment has been proven effective before but is only available in certain countries, and safety aspects play a part in reluctancy to prescribe this treatment. Patients, however, are usually keen on the use of phototherapy as it is effective and gives them the possibility of reducing the amount of topical treatment needed. In this study, we assess the effectivity of a low‐emission UV device used daily. Methods Sixty‐two patients were treated for 6 months either with daily low‐emission UV treatment and mometasone ointment 0.1% or with mometasone ointment 0.1% alone. Psoriasis severity scores, quality of life, vitamin D level, and blood pressure were monitored every 2 months during the study. Results Patients treated with daily low‐emission UV treatment showed a significant improvement in psoriasis severity, quality of life, amount of steroid ointment used, and vitamin D levels. Conclusion Daily low‐emission UV therapy is an effective treatment for psoriasis patients, diminishing the amount of steroid ointment needed and improving disease activity, quality of life, and vitamin D scores. Further investigation, however, is necessary.
Bibliography:ark:/67375/WNG-B55QSV92-X
ArticleID:PHPP12151
istex:29A3C34A1FBEE8DA5A8C85458246239AE92F484F
Conflicts of interest
Dr. S. Pavel has received consultancy fee from DermaSun Medical BV.DermaSun Medical BV provided and installed used devices free of charge. DermaSun Medical BV partly funded this study, they however had no involvement in analysing or processing the results, scientific input and had no input in the generation of this article.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0905-4383
1600-0781
DOI:10.1111/phpp.12151